Latest news with #XBIO

Yahoo
14-05-2025
- Business
- Yahoo
Xenetic Biosciences: Q1 Earnings Snapshot
FRAMINGHAM, Mass. (AP) — FRAMINGHAM, Mass. (AP) — Xenetic Biosciences, Inc. (XBIO) on Tuesday reported a loss of $903,000 in its first quarter. The Framingham, Massachusetts-based company said it had a loss of 59 cents per share. The company posted revenue of $593,300 in the period. Its adjusted revenue was $593,000. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on XBIO at


Washington Post
13-05-2025
- Business
- Washington Post
Xenetic Biosciences: Q1 Earnings Snapshot
FRAMINGHAM, Mass. — FRAMINGHAM, Mass. — Xenetic Biosciences, Inc. (XBIO) on Tuesday reported a loss of $903,000 in its first quarter. The Framingham, Massachusetts-based company said it had a loss of 59 cents per share. The company posted revenue of $593,300 in the period. Its adjusted revenue was $593,000. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on XBIO at


San Francisco Chronicle
13-05-2025
- Business
- San Francisco Chronicle
Xenetic Biosciences: Q1 Earnings Snapshot
FRAMINGHAM, Mass. (AP) — FRAMINGHAM, Mass. (AP) — Xenetic Biosciences, Inc. (XBIO) on Tuesday reported a loss of $903,000 in its first quarter. The Framingham, Massachusetts-based company said it had a loss of 59 cents per share. The company posted revenue of $593,300 in the period. Its adjusted revenue was $593,000. _____

Yahoo
13-05-2025
- Business
- Yahoo
Xenetic Biosciences: Q1 Earnings Snapshot
FRAMINGHAM, Mass. (AP) — FRAMINGHAM, Mass. (AP) — Xenetic Biosciences, Inc. (XBIO) on Tuesday reported a loss of $903,000 in its first quarter. The Framingham, Massachusetts-based company said it had a loss of 59 cents per share. The company posted revenue of $593,300 in the period. Its adjusted revenue was $593,000. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on XBIO at Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data